Geneva, April 27 -- International Clinical Trials Registry received information related to the study (TCTR20260401026) titled 'The Effect of a Gymnema Plant Supplement on Blood Sugar and Health in People at Risk for Diabetes' on April 1.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Industrial Research and Technology Capacity Development Program : IRTC
Condition:
Prediabetes
Impaired Glucose Homeostasis
Prediabetic State
Insulin Resistance
Metabolic Syndrome
Prediabetic State
Insulin Resistance
Metabolic Syndrome
Intervention:
Control product: 100% Chiangda powder capsules, 500 mg per capsule, 4 capsules/day by 2 capsules after breakfast and 2 capsules after dinner.
,Chiangda + cinnamon capsules, 500 mg per...